Details of the Drug

General Information of Drug (ID: DMLMS6J)

Drug Name

OTL-101

Indication

Disease Entry	ICD 11	Status	REF
Severe combined immunodeficiency	4A01.10	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Gene therapy

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04140539) A Clinical Study to Enable Process Validation of Commercial Grade OTL-101. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Orchard Therapeutics.